Skip to content
healthcare.dev

Triamterene and Hydrochlorothiazide

NDC 70518-4351, Triamterene and Hydrochlorothiazide, tablet, from REMEDYREPACK INC..

Product NDC
70518-4351
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216211
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-4351 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRIAMTERENE75 mg/1
  • HYDROCHLOROTHIAZIDE50 mg/1

Pharmacologic classes

Decreased Renal K+ Excretion [PE]; Increased Diuresis [PE]; Increased Diuresis [PE]; Potassium-sparing Diuretic [EPC]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
70518-4351-07051843510090 TABLET in 1 BOTTLE, PLASTIC (70518-4351-0)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5ee165a3-39a4-4d12-aff2-a6fb3309ce39

Use it

Look up 70518-4351 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-4351 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-4351. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.